Network News

Experimentica utilizes a validated mouse model of dry eye disease. Dry eye disease-like pathology is induced using transdermal scopolamine patches in combination with desiccating environmental stress. The induced pathology is characterized using corneal fluorescein staining, tear volume measurements, and histology for lacrimal gland infiltration, goblet cell loss, and corneal abnormalities. Dry eye disease, also referred […]

Foster City, Calif., and Munich, Germany – April 7, 2026 – Gilead Sciences, Inc. (Nasdaq: GILD) today announced it has entered into a definitive agreement to acquire Tubulis GmbH, a private Germany-based, clinical-stage biotechnology company developing next-generation antibody-drug conjugates (ADCs), building on Gilead’s oncology pipeline, focused on addressing areas of high unmet need. The acquisition significantly […]

The German Society for Trauma Surgery has jointly certified the Department of Trauma and Reconstructive Surgery at Heidelberg University Hospital (UKHD) and Agaplesion Bethanien Hospital Heidelberg as a Geriatric Trauma Center. The certification recognizes the outstanding care provided to elderly trauma patients at UKHD and underscores the great importance of interdisciplinary geriatric medicine. Full text […]

Former EMBL group leader returns to lead the organisation’s six sites at a time of change and opportunity in life sciences EMBL welcomes its new Director General, Tony Hyman, who will take up the mandate of leading EMBL’s six sites as the organisation enters its next phase. Hyman succeeds Interim Director Ewan Birney, who assumed leadership […]

Computer simulations and Artificial Intelligence are the main pillars of the “SIMPLAIX” collaboration, initiated by the Heidelberg Institute for Theoretical Studies (HITS). Together with colleagues from Heidelberg University and Karlsruhe Institute of Technology (KIT), HITS researchers are addressing challenges in the simulation of biomolecules and molecular materials by pooling their expertise in multiscale computer simulation […]

Sanofi’s Rezurock approved in the EU to treat chronic graft-vs-host disease Paris, March 31, 2026. The European Commission has granted a conditional marketing authorisation for Rezurock (belumosudil) for the treatment of chronic graft-versus-host disease (GVHD) in adults and in children aged 12 years and older with a body weight of at least 40 kg. The medicine is to […]

Full Text in German below. Strategische Investition in Deutschland: Roche weiht hochmodernes 90-Millionen-Euro-Distributionszentrum in Mannheim ein Mannheim, 23. März 2026 Mit einer Investition von 90 Millionen Euro stärkt Roche den Standort Mannheim als ein zentrales Drehkreuz im globalen Distributionsnetzwerk für Diagnostika des Unternehmens. Das neue Distributionszentrum für Europa umfasst eine Fläche von rund 16.300 Quadratmetern, […]

It is a beacon in the Rhine-Neckar metropolitan region: The Heidelberg-based research company BioMed X is developing new approaches to drug development at the intersection of science and industry – currently, for example, through “XFem Labs,” a women’s health project funded by the Gates Foundation. Full Text in German below. BioMed X: Regionale Power für […]

Heidelberg, March 18, 2026 – At yesterday’s meeting of the Board of Trustees of the German Cancer Research Center (DKFZ), the board decided to become the fifth shareholder of InnovationLab GmbH (iL). In addition to BASF SE and HEIDELBERG (Heidelberger Druckmaschinen AG), the Karlsruhe Institute of Technology (KIT) and the Ruprecht-Karls University of Heidelberg are […]